FFA
OGN icon

Freedman Financial Associates’s Organon & Co OGN Stock Holding History

Freedman Financial Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-461
Closed -$16K – 288
2022
Q1 		$16K Hold
461
– – 0.01% 319
2021
Q4 		$14K Hold
461
– – 0.01% 315
2021
Q3 		$15K Hold
461
– – 0.01% 317
2021
Q2 		$14K Buy
+461
New +$15.2K 0.01% 318

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Freedman Financial Associates's OGN Position: Q2 2022 in Review

Freedman Financial Associates sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 461 shares — an estimated $16K sold.

Freedman Financial Associates first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $16K in Q1 2022. 852 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Freedman Financial Associates reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 461 Organon & Co shares in Q2 2022, an estimated $16K.
  • Freedman Financial Associates first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Freedman Financial Associates's Organon & Co position peaked at $16K in Q1 2022.
  • 852 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.